
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 62.950 | 138.960 | 76.010 |
Shares | 34.920 | 96.000 | 61.080 |
Bonds | 2.140 | 2.140 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 25.188 | 15.216 |
Price to Book | 2.888 | 1.900 |
Price to Sales | 2.120 | 1.274 |
Price to Cash Flow | 10.746 | 8.223 |
Dividend Yield | 1.622 | 3.290 |
5 Years Earnings Growth | 7.510 | 10.785 |
Name | Net % | Category Average |
---|---|---|
Consumer Cyclical | 24.570 | 14.298 |
Technology | 18.400 | 12.704 |
Healthcare | 15.380 | 12.074 |
Basic Materials | 13.950 | 7.716 |
Industrials | 8.100 | 21.318 |
Financial Services | 7.590 | 12.356 |
Communication Services | 5.850 | 10.288 |
Real Estate | 3.650 | 4.012 |
Consumer Defensive | 2.520 | 4.778 |
Number of long holdings: 99
Number of short holdings: 68
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
BASF | DE000BASF111 | 8.57 | 42.020 | -3.07% | |
Puma SE | DE0006969603 | 6.12 | 22.15 | -1.25% | |
ASM | NL0000334118 | 5.55 | 504.00 | -5.19% | |
Allianz | DE0008404005 | 3.68 | 342.10 | +0.71% | |
Carmignac L-S Eurp Eqs A Eur Acc | FR0010149179 | 3.47 | - | - | |
Cara Therapeutics Inc | - | 3.17 | - | - | |
Dermapharm | DE000A2GS5D8 | 2.89 | 34.55 | 0.00% | |
Dj Stoxx 1St Fri Y 3600 | DE000C5297M5 | 2.76 | - | - | |
Prada SpA | IT0003874101 | 2.76 | 49.30 | -0.40% | |
Deutsche Wohnen | DE000A0HN5C6 | 2.72 | 22.900 | -0.65% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Carmignac LongShortEurEqF GBP AccHd | 640.18M | 2.67 | 5.84 | 5.80 | ||
CarmignacEmergentsW GBP Acc | 388.39M | 0.86 | 3.50 | 6.27 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review